Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)
Submitted by Anonymous (not verified) on 13 March 2026 - 13:20
Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 March 2026
Submitted by Anonymous (not verified) on 13 March 2026 - 13:15
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 March 2026
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 March 2026
Submitted by Anonymous (not verified) on 13 March 2026 - 11:00
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 March 2026
Appendix 1: Acceptable intakes established for N-nitrosamines
Submitted by Anonymous (not verified) on 13 March 2026 - 9:55
Appendix 1: Acceptable intakes established for N-nitrosamines
EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 5: Example payloads for API
Submitted by Anonymous (not verified) on 13 March 2026 - 9:37
EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 5: Example payloads for API
Records of data processing activity relating to temporary agency workers (interims)
Submitted by Anonymous (not verified) on 13 March 2026 - 9:12
Records of data processing activity relating to temporary agency workers (interims)
European Medicines Agency’s data protection notice for women leadership development and mentoring activities
Submitted by Anonymous (not verified) on 13 March 2026 - 9:08
European Medicines Agency’s data protection notice for women leadership development and mentoring activities
Minutes - HMA-EMA joint Network Data Steering Group meeting - 11 February 2026
Submitted by Anonymous (not verified) on 13 March 2026 - 8:29
Minutes - HMA-EMA joint Network Data Steering Group meeting - 11 February 2026
Concept paper on the development of a reflection paper on proof-of-concept data to support the development of anti-cancer medicinal products in paediatric patients
Submitted by Anonymous (not verified) on 13 March 2026 - 7:00
Concept paper on the development of a reflection paper on proof-of-concept data to support the development of anti-cancer medicinal products in paediatric patients
Development of anti-cancer medicinal products in paediatric patients - Scientific guideline
Submitted by Anonymous (not verified) on 13 March 2026 - 7:00
Development of anti-cancer medicinal products in paediatric patients - Scientific guideline